Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ingvar

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Head & Neck|August 24, 2017
Benefits of initial CT staging before sentinel lymph node biopsy in patients with head and neck cutaneous melanomaAnna Hafström, Maria Silfverschiöld, Simon S Persson, et al.
Cancer|September 17, 2004
Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factorsChrister Lindholm, Ronny Andersson, Monika Dufmats, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
(68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodesRenata Madru, Thuy A Tran, Johan Axelsson, et al.
International Journal of Cancer|September 16, 2016
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor sizeMaria Simonsson, Sofie Björner, Andrea Markkula, et al.
Lancet (London, England)|October 27, 2011
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trialPeter Gillgren, Krzysztof T Drzewiecki, Marianne Niin, et al.
The British Journal of Dermatology|January 23, 2023
Association of metformin use and survival in patients with cutaneous melanoma and diabetesIsabelle Krakowski, Henrike Häbel, Kari Nielsen, et al.
Oncotarget|December 29, 2016
Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groupsSofie Björner, Ann H Rosendahl, Maria Simonsson, et al.
Frontiers in Endocrinology|December 14, 2017
Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast CancerSofie Björner, Ann H Rosendahl, Maria Simonsson, et al.
Frontiers in Endocrinology|June 22, 2018
Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy TreatmentSofie Björner, Ann H Rosendahl, Helga Tryggvadottir, et al.
Melanoma Research|September 18, 2010
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patternsKatja Harbst, Johan Staaf, Anna Måsbäck, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Head & Neck|August 24, 2017
Benefits of initial CT staging before sentinel lymph node biopsy in patients with head and neck cutaneous melanomaAnna Hafström, Maria Silfverschiöld, Simon S Persson, et al.
Cancer|September 17, 2004
Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factorsChrister Lindholm, Ronny Andersson, Monika Dufmats, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
(68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodesRenata Madru, Thuy A Tran, Johan Axelsson, et al.
International Journal of Cancer|September 16, 2016
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor sizeMaria Simonsson, Sofie Björner, Andrea Markkula, et al.
Lancet (London, England)|October 27, 2011
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trialPeter Gillgren, Krzysztof T Drzewiecki, Marianne Niin, et al.
The British Journal of Dermatology|January 23, 2023
Association of metformin use and survival in patients with cutaneous melanoma and diabetesIsabelle Krakowski, Henrike Häbel, Kari Nielsen, et al.
Oncotarget|December 29, 2016
Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groupsSofie Björner, Ann H Rosendahl, Maria Simonsson, et al.
Frontiers in Endocrinology|December 14, 2017
Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast CancerSofie Björner, Ann H Rosendahl, Maria Simonsson, et al.
Frontiers in Endocrinology|June 22, 2018
Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy TreatmentSofie Björner, Ann H Rosendahl, Helga Tryggvadottir, et al.
Melanoma Research|September 18, 2010
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patternsKatja Harbst, Johan Staaf, Anna Måsbäck, et al.
Pageof 15